PEGOZAFERMIN
UNII UO870O6MFS

Substance Identification & Data

This profile provides standardized clinical and technical data for Pegozafermin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UO870O6MFS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2489589-60-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

UO870O6MFS

CAS Registry Number

2489589-60-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PEGOZAFERMIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C188638

National Cancer Institute reference terminology for clinical and research data.

INN ID

12406

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-214

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pegozafermin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PEGOZAFERMIN

Common Names & Synonyms

BIO89-100 (LONG-ACTING GLYCOPEGYLATED FIBROBLAST GROWTH FACTOR 21 (FGF21) ANALOGUE)

FIBROBLAST GROWTH FACTOR 21 (METHIONYL,173-(O-(2-(ACETYLAMINO)-6-O-(N-(2-(CARBOXYAMINO)ACETYL)-.ALPHA.-NEURAMINOSYL)-2-DEOXY-.ALPHA.-D-GALACTOPYRANOSYL)THREONINE),176-ARGININE) (HUMAN CONSTRUCT BIO89-100), 173N-ESTER WITH .ALPHA.-HYDRO-.OMEGA.-METHOXYPOLY(OXY-1,2-ETHANEDIYL)

PEGOZAFERMIN [INN]

PEGOZAFERMIN [USAN]